英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
hindered查看　hindered　在百度字典中的解释百度英翻中〔查看〕
hindered查看　hindered　在Google字典中的解释Google英翻中〔查看〕
hindered查看　hindered　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • FDA approves a second Alzheimers drug, Eli Lillys Kisunla . . .
    U S health officials have approved a new Alzheimer’s drug that can modestly slow the disease It's only the second drug that's been convincingly shown to slow the memory-destroying condition FDA approves a second Alzheimer's drug, Eli Lilly's Kisunla | AP News
  • FDA approves treatment for adults with Alzheimer’s disease
    Action The U S Food and Drug Administration has approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease Treatment with Kisunla should be initiated in patients
  • Alzheimer’s Association Welcomes U. S. FDA Approval of Kisunla . . .
    CHICAGO, July 2, 2024 — The Alzheimer’s Association celebrates today’s U S Food and Drug Administration (FDA) action to approve Kisunla™ (donanemab, Eli Lilly) for the treatment of people living with early symptomatic Alzheimer’s disease, which includes mild cognitive impairment and the mild dementia stage of Alzheimer’s disease, with confirmed amyloid plaques
  • FDA approves new Alzheimers treatment, donanemab from Eli . . .
    FDA approves new treatment to slow progression of early Alzheimer's 02:45 The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for
  • Lillys Kisunla™ (donanemab-azbt) Approved by the FDA for the . . .
    INDIANAPOLIS, July 2, 2024 PRNewswire -- The U S Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg 20 mL once-monthly injection for IV infusion), Eli Lilly and Company's (NYSE: LLY) Alzheimer's treatment for adults with early symptomatic Alzheimer's disease (AD), which includes people with mild cognitive





中文字典-英文字典  2005-2009